The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Four-year follow-up from a phase 2 study of obinutuzumab, ibrutinib, and venetoclax in CLL.
 
Kerry Anne Rogers
Consulting or Advisory Role - Abbvie; Acerta Pharma; AstraZeneca; BeiGene; Genentech; Innate Pharma; Pharmacyclics
Research Funding - Abbvie (Inst); Genentech (Inst); Janssen (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Ying Huang
No Relationships to Disclose
 
Lynne Abruzzo
Patents, Royalties, Other Intellectual Property - Royalties from a licensing agreement for a patent held by the University of Maryland.
 
Seema Ali Bhat
Honoraria - ArQule
Consulting or Advisory Role - AstraZeneca; BeiGene; Janssen
 
Tzyy-Jye Doong
No Relationships to Disclose
 
Adam Kittai
Consulting or Advisory Role - Abbvie; Beigene; Bristol-Myers Squibb; Janssen
 
Arletta Lozanski
No Relationships to Disclose
 
Gerard Lozanski
Research Funding - Genentech (Inst)
 
Margaret Lucas
No Relationships to Disclose
 
Kami J. Maddocks
Honoraria - ADC Therapeutics; AstraZeneca/Merck; BeiGene; BMS; Celgene; Epizyme; Genentech; Genmab; Incyte; Karyopharm Therapeutics; Kite, a Gilead company; Lilly; MorphoSys; Pharmacyclics; Seagen
Research Funding - Bristol-Myers Squibb; Merck; Pharmacyclics
 
Charelen Mao
No Relationships to Disclose
 
Megan Nussbaum
No Relationships to Disclose
 
Ellen J Sass
No Relationships to Disclose
 
Swetha Suresh
No Relationships to Disclose
 
John C. Byrd
Stock and Other Ownership Interests - Vincerx Pharma
Honoraria - AstraZeneca; Novartis; Novartis; Syndax; Trillium Therapeutics
Consulting or Advisory Role - AstraZeneca; Janssen; Kura Oncology; Novartis; Syndax
Research Funding - Acerta Pharma (Inst); Pharmacyclics (Inst); Zencor
Patents, Royalties, Other Intellectual Property - OSU Patents (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Janssen; Novartis; Pharmacyclics; TG Therapeutics
 
Jennifer Ann Woyach
Consulting or Advisory Role - AstraZeneca; Beigene; Genentech; Janssen; Loxo; Newave Pharmaceutical; Pharmacyclics
Research Funding - Abbvie; Janssen; Karyopharm Therapeutics; MorphoSys; Schrodinger